Search and analyze individual stocks with comprehensive metrics
Novateor Research Laboratories Ltd
Fundamental Score
Novateor Research Laboratories Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of NOVATEOR across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Revenue Growth (212.66%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (48.11% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (58.49% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (58.49% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.06)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Balanced Promoter Holding (50.90%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
12 factors identified
Below-Average Return on Equity (0.83%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (1.69%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-21.36%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Premium Valuation Risk (P/E: 506.33x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-166.67%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Weak Interest Coverage (1.60x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-5.20 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Loading Peer Comparison
Finding companies in the Personal Care sector...
Financial Statements
Comprehensive financial data for Novateor Research Laboratories Ltd
About NOVATEOR
Business Overview
Novateor Research Laboratories Limited engages in the development, manufacture, and sale novel personal care products in India. It offers tongue cleaners, teeth whitening strips, toothpastes, toothbrushes and accessories, denture products, mouthwashes/rinses, dental accessories/ancillaries, and dental prosthesis cleaning solutions. The company sells its products through dentists and cosmetic parlors to end users. It offers teeth whitening products under SmiloShine brand. The company was formerly known as Novateor Research Laboratories Private Limited and changed its name to Novateor Research Laboratories Limited in April 2019. Novateor Research Laboratories Limited was incorporated in 2011 and is based in Ahmedabad, India.
Company Details
Key Leadership
Latest News
NOVATEOR Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Novateor Research Laboratories Ltd (NOVATEOR)?
As of 15 Jan 2026, 09:52 am IST, Novateor Research Laboratories Ltd (NOVATEOR) is currently trading at ₹34.50. The stock has a market capitalization of ₹15.19 (Cr).
Is NOVATEOR share price Overvalued or Undervalued?
NOVATEOR is currently trading at a P/E ratio of 506.33x, compared to the industry average of 50.39x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Novateor Research Laboratories Ltd share price?
Key factors influencing NOVATEOR's price include its quarterly earnings growth (Sales Growth: 212.66%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Novateor Research Laboratories Ltd a good stock for long-term investment?
Novateor Research Laboratories Ltd shows a 5-year Profit Growth of 58.49% and an ROE of 0.83%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.06 before investing.
How does Novateor Research Laboratories Ltd compare with its industry peers?
Novateor Research Laboratories Ltd competes with major peers in the Personal Care. Investors should compare NOVATEOR's P/E of 506.33x and ROE of 0.83% against the industry averages to determine its competitive standing.
What is the P/E ratio of NOVATEOR and what does it mean?
NOVATEOR has a P/E ratio of 506.33x compared to the industry average of 50.39x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹506 for every ₹1 of annual earnings.
How is NOVATEOR performing according to Bull Run's analysis?
NOVATEOR has a Bull Run fundamental score of 44/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does NOVATEOR belong to?
NOVATEOR operates in the Personal Care industry. This classification helps understand the competitive landscape and sector-specific trends affecting Novateor Research Laboratories Ltd.
What is Return on Equity (ROE) and why is it important for NOVATEOR?
NOVATEOR has an ROE of 0.83%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Novateor Research Laboratories Ltd generates profits from shareholders' equity.
How is NOVATEOR's debt-to-equity ratio and what does it indicate?
NOVATEOR has a debt-to-equity ratio of 0.06, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is NOVATEOR's dividend yield and is it a good dividend stock?
NOVATEOR offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has NOVATEOR grown over the past 5 years?
NOVATEOR has achieved 5-year growth rates of: Sales Growth 48.11%, Profit Growth 58.49%, and EPS Growth 58.49%.
What is the promoter holding in NOVATEOR and why does it matter?
Promoters hold 50.90% of NOVATEOR shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is NOVATEOR's market capitalization category?
NOVATEOR has a market capitalization of ₹15 crores, placing it in the Small-cap category.
How volatile is NOVATEOR stock?
NOVATEOR has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for NOVATEOR?
NOVATEOR has a 52-week high of ₹N/A and low of ₹N/A.
What is NOVATEOR's operating profit margin trend?
NOVATEOR has a 5-year average Operating Profit Margin (OPM) of -21.36%, indicating the company's operational efficiency.
How is NOVATEOR's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 212.66% and YoY Profit Growth of -166.67%.
What is the institutional holding pattern in NOVATEOR?
NOVATEOR has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.